Related Articles
REMS Required
How will this FDA drug safety program affect rheumatology offices?
Drug UPDATES
Information on New Approvals and Medication Safety
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
Rheumatology Drugs at a Glance, Part 3: Rheumatoid Arthritis
Over the past few years, biosimilars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug options, others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and small molecule inhibitor drugs…